Foghorn’s Phase I AML/MDS trial on FDA partial clinical hold due to subject death
No new subjects will be enrolled in the trial until the FDA lifts the partial clinical hold.
Clinical Trials
Latest in
Clinical Trials
Indaptus to commence Phase I trial of solid tumour therapy
The company received FDA clearance for the IND application to initiate the trial.
Headlands, Pfizer collaborate to boost clinical trial diversity
Under the collaboration, the first trial site will be opened at a new facility of Headlands in Brownsville, Texas, US.
Dengue fever: the urgent hunt for antivirals and vaccines
There are 100–400 million Dengue fever infections each year, and cases are quickly rising. How can manufacturers overcome obstacles to…
By
Suvoda announces availability of eConsent to simplify trial consent process
eConsent offers the flexibility to include differences in regulations by country, consent methods, consent types and device needs.
Cerner, Elligo, Freenome enters partnership to boost cancer clinical trial access
The partnership will allow participation of diverse patients from various demographics and socio-economic factors.
AIM ImmunoTech provides Phase III efficacy update on Ampligen for long Covid
Treatment with investigational drug Ampligen for a minimum of 12 weeks offered a decline in fatigue in long Covid patients.
Women’s health clinical trials: breaking down barriers through decentralisation
Women tend to be harder to recruit for clinical trials due to socioeconomic factors. But decentralised study designs help ease…
By